Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
Proc Natl Acad Sci U S A ; 113(47): E7554-E7563, 2016 11 22.
Article in English | MEDLINE | ID: mdl-27821775

ABSTRACT

Appreciation of the role of the gut microbiome in regulating vertebrate metabolism has exploded recently. However, the effects of gut microbiota on skeletal growth and homeostasis have only recently begun to be explored. Here, we report that colonization of sexually mature germ-free (GF) mice with conventional specific pathogen-free (SPF) gut microbiota increases both bone formation and resorption, with the net effect of colonization varying with the duration of colonization. Although colonization of adult mice acutely reduces bone mass, in long-term colonized mice, an increase in bone formation and growth plate activity predominates, resulting in equalization of bone mass and increased longitudinal and radial bone growth. Serum levels of insulin-like growth factor 1 (IGF-1), a hormone with known actions on skeletal growth, are substantially increased in response to microbial colonization, with significant increases in liver and adipose tissue IGF-1 production. Antibiotic treatment of conventional mice, in contrast, decreases serum IGF-1 and inhibits bone formation. Supplementation of antibiotic-treated mice with short-chain fatty acids (SCFAs), products of microbial metabolism, restores IGF-1 and bone mass to levels seen in nonantibiotic-treated mice. Thus, SCFA production may be one mechanism by which microbiota increase serum IGF-1. Our study demonstrates that gut microbiota provide a net anabolic stimulus to the skeleton, which is likely mediated by IGF-1. Manipulation of the microbiome or its metabolites may afford opportunities to optimize bone health and growth.


Subject(s)
Bone Development , Bone and Bones/metabolism , Gastrointestinal Microbiome , Insulin-Like Growth Factor I/metabolism , Adipose Tissue/metabolism , Animals , Fatty Acids, Volatile/metabolism , Female , Liver/metabolism , Male , Mice , Osteogenesis , Specific Pathogen-Free Organisms
2.
Work ; 40(4): 459-71, 2011.
Article in English | MEDLINE | ID: mdl-22130063

ABSTRACT

OBJECTIVE: To evaluate the My Health Matters! (MHM) program, a multifaceted workplace intervention relying on education and awareness, early detection and disease management with a focus on risk factors for metabolic syndrome. PARTICIPANTS: The MHM program was offered to 2,000 public servants working in more than 30 worksites in British Columbia, Canada. METHODS: The MHM program included a health risk assessment combined with an opportunity to attend an on-site screening and face-to-face call back visits and related on-site educational programs. Clinical and economic outcomes were collected over time in this one-year prospective study coupled with administrative and survey data. RESULTS: Forty three per cent of employees (N=857) completed the online HRA and 23 per cent (N=447) attended the initial clinical visit with the nurse. Risk factors for metabolic syndrome were identified in more than half of those attending the clinical visit. The number of risk factors significantly decreased by 15 per cent over six months (N=141). The cost per employee completing the HRA was $205 while the cost per employee attending the initial clinical visit was $394. Eighty-two per cent of employees would recommend the program to other employers. CONCLUSIONS: This study supports that workplace interventions are feasible, sustainable and valued by employees. As such, this study provides a new framework for implementing and evaluating workplace interventions focussing on metabolic disorders.


Subject(s)
Health Promotion , Metabolic Syndrome/prevention & control , Occupational Health , Adult , British Columbia , Female , Health Promotion/economics , Humans , Male , Mass Screening , Metabolic Syndrome/diagnosis , Metabolic Syndrome/etiology , Middle Aged , Occupational Health/economics , Patient Education as Topic , Program Evaluation , Risk Assessment , Risk Factors , Workplace
5.
Hum Gene Ther ; 12(11): 1383-94, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11485630

ABSTRACT

A phase I clinical trial was conducted in which recombinant adenovirus containing the cystic fibrosis trans-membrane regulator (CFTR) (Ad2/CFTR) was administered by bronchoscopic instillation or aerosolization to the lungs of cystic fibrosis (CF) patients. In this paper, we evaluate the efficiency of Ad2/CFTR-mediated transduction of bronchial airway cells. The ability of an Ad2/CFTR vector to transduce airway cells was first evaluated in patients to whom the vector was administered by bronchoscopic instillation. Cells at the administration site were collected 2 days after treatment by bronchoscopic brushing. Ad2-specific CFTR DNA was detected in four of five individuals by PCR, and Ad2-specific CFTR RNA was detected in three of five individuals by RT-PCR. Ad2/CFTR-mediated transduction of airway epithelial cells was then determined in CF individuals receiving this vector by aerosol inhalation. Ad2-specific CFTR DNA was detected in 13 of 13 individuals 2 days after aerosolization, and in 3 of 5 individuals 7 days after aerosolization. Ad2-specific RNA was detected in 4 of 13 individuals on day 2, but was not detected in the 5 individuals tested on day 7. The percentage of airway epithelial cells containing nuclear-localized vector DNA was < or =2.4% as determined by fluorescence in situ hybridization (FISH). However, in some cases, a high percentage of nonepithelial mononuclear cells or squamous metaplastic epithelial cells was infected with the adenoviral vector. In conclusion, aerosol administration is a feasible means to distribute adenoviral vectors throughout the conducting airways, but improvements in adenovirus-mediated transduction of airway epithelial cells are necessary before gene therapy for CF will be effective.


Subject(s)
Adenoviridae/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , Respiratory Mucosa/metabolism , Transfection , Administration, Inhalation , Adolescent , Adult , Bronchoscopy , DNA, Recombinant , Female , Genetic Vectors , Humans , In Situ Hybridization, Fluorescence , Instillation, Drug , Male , Polymerase Chain Reaction , RNA, Messenger/metabolism , Recombinant Proteins/isolation & purification , Time Factors , Transduction, Genetic
6.
Hum Gene Ther ; 12(11): 1369-82, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11485629

ABSTRACT

Cystic fibrosis (CF), an autosomal recessive disorder resulting from mutations in the cystic fibrosis trans-membrane conductance regulator (CFTR) gene, is the most common lethal genetic illness in the Caucasian population. Gene transfer to airway epithelium, using adenoviruses containing normal CFTR cDNA, leads to transient production of CFTR mRNA and, in some studies, to correction of the airway epithelial ion transport defect caused by dysfunctional CFTR. Inflammatory responses to the adenoviral vector have been reported, particularly at high viral titers. We evaluated the effects of adenovirus-mediated CFTR gene transfer to airway epithelium in 36 subjects with CF (34 individuals, 2 of whom received two separate doses of vector), 20 by lobar instillation and 16 by aerosol administration. Doses ranged from 8 x 10(6) to 2.5 x 10(10) infective units (IU), in 0.5-log increments. After lobar administration of low doses there were occasional reports of cough, low-grade temperature, and myalgias. At the highest lobar dose (2.5 x 10(9) IU) two of three patients had transient myalgias, fever, and increased sputum production with obvious infiltrates on CT scan. After aerosol administration there were no significant systemic symptoms until the 2.5 x 10(10) IU dose, when both patients experienced myalgias and fever that resolved within 24 hr. There were no infiltrates seen on chest CT scans in any of the patients in the aerosol administration group. There were no consistent changes in pulmonary function tests or any significant rise in serum IgG or neutralizing antibodies in patients from either group. Serum, sputum, and nasal cytokines, measured before and after vector administration, showed no correlation with adenoviral dose. Gene transfer to lung cells was inefficient and expression was transient. Cells infected with the vector included mononuclear inflammatory cells as well as cuboidal and columnar epithelial cells. In summary, we found no consistent immune response, no evidence of viral shedding, and no consistent change in pulmonary function in response to adenovirus-mediated CFTR gene transfer. At higher doses there was a mild, nonspecific inflammatory response, as evidenced by fevers and myalgias. Overall, vector administration was tolerated but transfer of CFTR cDNA was inefficient and transgene expression was transient for the doses and method of administration used here.


Subject(s)
Adenoviridae/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , Gene Transfer Techniques , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Administration, Inhalation , Adolescent , Adult , Bronchoscopy , Cystic Fibrosis/diagnostic imaging , Cystic Fibrosis/virology , Cystic Fibrosis Transmembrane Conductance Regulator/administration & dosage , DNA, Recombinant/administration & dosage , DNA, Recombinant/genetics , Female , Genetic Therapy/adverse effects , Humans , Inflammation/etiology , Lung/immunology , Lung/virology , Male , Respiratory Mucosa/cytology , Tomography, X-Ray Computed
7.
Vet Surg ; 29(3): 207-17, 2000.
Article in English | MEDLINE | ID: mdl-10871222

ABSTRACT

OBJECTIVE: To describe the surgical technique and clinical results of treatment for forelimb angular limb deformities, secondary to premature distal radial or ulnar physeal closure, by using T-plate fixation of a distal radial closing wedge osteotomy in 18 dogs. STUDY DESIGN: Retrospective clinical study. SAMPLE POPULATION: 18 client-owned dogs. METHODS: The medical records of 18 dogs that underwent a distal radial closing wedge osteotomy with T-plate fixation for correction of a forelimb angular limb deformity were reviewed. Small pins (Kirschner wires) were used to obtain the appropriate alignment of the antebrachiocarpal and elbow joints and proper limb orientation. In-hospital follow-up evaluation was obtained at the time fracture healing was observed radiographically. Further long-term follow-up was obtained by owner interview. RESULTS: Osteotomy sites were radiographically healed within 4 to 12 weeks (mean, 8 weeks) after surgery in the 14 dogs that returned for in-hospital follow-up. Limb function was graded as good or excellent in all dogs. Long-term follow-up by owner interview rated limb function and cosmetic appearance as good to excellent in all dogs. Plate removal was necessary in one dog 7 months after surgery because of osteopenia in the radius. CONCLUSION: This surgical technique was considered successful in the treatment of angular limb deformities in all dogs. A good to excellent prognosis is to be expected with this technique, with minimal complications. CLINICAL RELEVANCE: The use of a T-plate for the correction of angular limb deformities has not been previously described in the literature. This technique permits accurate correction of the angular limb deformity and minimizes postoperative complications.


Subject(s)
Bone Plates/veterinary , Dogs/abnormalities , Dogs/surgery , Forelimb/abnormalities , Forelimb/surgery , Animals , Female , Follow-Up Studies , Forelimb/diagnostic imaging , Forelimb/growth & development , Male , Osteotomy/veterinary , Radiography , Radius/abnormalities , Radius/surgery , Records/veterinary , Retrospective Studies , Treatment Outcome , Ulna/abnormalities , Ulna/surgery
8.
Lancet ; 353(9157): 947-54, 1999 Mar 20.
Article in English | MEDLINE | ID: mdl-10459902

ABSTRACT

BACKGROUND: We and others have previously reported significant changes in chloride transport after cationic-lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator (CFTR) gene to the nasal epithelium of patients with cystic fibrosis. We studied the safety and efficacy of this gene transfer to the lungs and nose of patients with cystic fibrosis in a double-blind placebo-controlled trial. METHODS: Eight patients with cystic fibrosis were randomly assigned DNA-lipid complex (active) by nebulisation into the lungs followed 1 week later by administration to the nose. Eight control patients followed the same protocol but with the lipid alone (placebo). Safety was assessed clinically, by radiography, by pulmonary function, by induced sputum, and by histological analysis. Efficacy was assessed by analysis of vector-specific CFTR DNA and mRNA, in-vivo potential difference, epifluorescence assay of chloride efflux, and bacterial adherence. FINDINGS: Seven of the eight patients receiving the active complex reported mild influenza-like symptoms that resolved within 36 h. Six of eight patients in both the active and placebo groups reported mild airway symptoms over a period of 12 h following pulmonary administration. No specific treatment was required for either event. Pulmonary administration resulted in a significant (p<0.05) degree of correction of the chloride abnormality in the patients receiving active treatment but not in those on placebo when assessed by in-vivo potential difference and chloride efflux. Bacterial adherence was also reduced. We detected no alterations in the sodium transport abnormality. A similar pattern occurred following nasal administration. INTERPRETATION: Cationic-lipid-mediated CFTR gene transfer can significantly influence the underlying chloride defect in the lungs of patients with cystic fibrosis.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , Genetic Therapy , Adult , Bacterial Adhesion , Chlorides/metabolism , Cystic Fibrosis/diagnostic imaging , Cystic Fibrosis/microbiology , Cystic Fibrosis/pathology , Cystic Fibrosis/physiopathology , DNA, Complementary/analysis , DNA, Complementary/genetics , Double-Blind Method , Epithelium/metabolism , Gene Transfer Techniques , Humans , Lipids , Lung/metabolism , Lung/physiopathology , Male , Nasal Mucosa/metabolism , Nebulizers and Vaporizers , Placebos , RNA, Messenger/analysis , Radiography , Safety , Sputum/metabolism
9.
J Obstet Gynaecol ; 19(2): 164-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-15512261

ABSTRACT

Laparoscopic assisted vaginal hysterectomy continues to gain popularity worldwide without evidence from any controlled trials of its superiority over existing techniques. There is some concern over complication rates particularly damage to the urinary tract and haemorrhage. The Royal College of Obstetricians and Gynaecologists has compiled a register of preceptors for advanced laparoscopic surgery, however there is nothing to prevent a surgeon without adequate training or experience from embarking upon any form of minimal access surgery. This series consists of 190 cases performed by one surgeon in a District General Hospital over the past five years. The mean operating time was 87 minutes and the mean hospital stay 2.7 days. There were nine failures. The incidence of late urinary tract damage was 1.6% and haemorrhage requiring transfusion 3.7%. Both the complication and failure rate fell slowly with experience, implying that the surgical learning period is significantly longer than with conventional surgery. With better selection it is felt that these figures can be further improved.

10.
J Clin Invest ; 100(6): 1529-37, 1997 Sep 15.
Article in English | MEDLINE | ID: mdl-9294121

ABSTRACT

Cationic lipids show promise as vectors for transfer of CFTR cDNA to airway epithelia of patients with cystic fibrosis (CF). However, previous studies have not compared the effect of DNA-lipid to DNA alone. Recently, we developed a formulation of plasmid encoding CFTR (pCF1-CFTR) and cationic lipid (GL-67:DOPE) that generated greater gene transfer in mouse lung than previously described DNA-lipid vectors. Therefore, we tested the hypothesis that DNA-lipid complexes were more effective than DNA alone at transferring CFTR cDNA to airway epithelia in vivo. We administered complexes of DNA-lipid to one nostril and DNA alone to the other nostril in a randomized, double-blind study. Electrophysiologic measurements showed that DNA-lipid complexes partially corrected the Cl- transport defect. Importantly, the pCF1-CFTR plasmid alone was at least as effective as complexes of DNA with lipid. Measurements of vector-specific CFTR transcripts also showed gene transfer with both DNA-lipid and DNA alone. These results indicate that nonviral vectors can transfer CFTR cDNA to airway epithelia and at least partially restore the Cl- transport defect characteristic of CF. However, improvements in the overall efficacy of gene transfer are required to develop a treatment for CF.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Cystic Fibrosis/therapy , DNA/administration & dosage , Gene Transfer Techniques , Nasal Mucosa/metabolism , Adolescent , Adult , Amiloride/pharmacology , Chlorine/pharmacology , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/immunology , DNA/immunology , DNA/pharmacokinetics , Dose-Response Relationship, Drug , Double-Blind Method , Evaluation Studies as Topic , Female , Genetic Vectors , Humans , Interleukin-6/blood , Lipids/immunology , Lipids/pharmacokinetics , Male , Membrane Potentials/drug effects , Middle Aged , Nasal Mucosa/drug effects , Nasal Mucosa/physiology , Polymerase Chain Reaction , Terbutaline/pharmacology , Time Factors , Treatment Outcome
11.
J Obstet Gynaecol ; 17(2): 163, 1997 Mar.
Article in English | MEDLINE | ID: mdl-15511810
12.
Gene Ther ; 4(9): 937-42, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9349430

ABSTRACT

Several groups are assessing the use of cationic lipids for respiratory gene therapy. To date no human data are available regarding the safety of intra-pulmonary cationic lipid delivery. In preparation for a trial of pulmonary delivery of the CFTR gene, we have assessed the safety of nebulised lipid GL-67/DOPE/DMPE-PEG5000 (GL-67A), the cationic lipid formulation to be used in this study. Fifteen healthy volunteers were given incremental doses of GL-67A via a Pari LC Jet nebuliser; three volunteers in each of five dosing cohorts with a week interval between cohorts. Markers of safety included clinical assessment, measurement of lung function, chest CT scan, serological testing and analysis of induced sputum. Measurements were taken before administration and at intervals up to 21 days thereafter. No adverse clinical events were seen or any statistically significant changes in spirometry or gas transfer. There were no clinically significant changes in any of the blood parameters and no CT changes were seen. Comparisons of the cellular subpopulations (neutrophils, eosinophils, lymphocytes and macrophages) in induced sputum showed no significant alterations following administration of the GL-67A. This study suggests that a single application of aerosol formulation of GL-67A does not result in clinically detectable changes when given by nebulisation into the lungs of normal volunteers and provides an indication of a lipid dose tolerated in man.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Gene Transfer Techniques , Genetic Therapy/methods , Lipids/administration & dosage , Lung/drug effects , Aerosols , Cations , Cystic Fibrosis/therapy , Drug Administration Schedule , Evaluation Studies as Topic , Female , Humans , Lipids/therapeutic use , Male
14.
J Clin Invest ; 97(6): 1504-11, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8617884

ABSTRACT

Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator gene. Recombinant adenoviruses have shown promise as vectors for transfer of CF transmembrane conductance regulator cDNA to airway epithelia and correction of the Cl- transport defect. However, because adenovirus-mediated gene transfer is transient, use of adenovirus as a vector for treatment of CF would require repeated administration. Therefore, we evaluated repeat administration of an adenovirus vector to the nasal epithelium of patients with CF with five escalating doses of up to 10(10) infectious units. There were no detectable adverse affects. All subjects were initially seropositive but developed additional humoral immune responses. The vector partially corrected the defect in airway epithelial Cl- transport in some subjects, although there was variability between subjects and there was less correction with subsequent administration, perhaps because the immune response limited gene transfer. Future work must focus on vectors with increased efficiency and with the ability to evade host defenses.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/therapeutic use , Cystic Fibrosis/therapy , Nasal Mucosa/metabolism , Adenoviridae , Adult , Cystic Fibrosis/genetics , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Drug Delivery Systems , Epithelium/metabolism , Female , Gene Transfer Techniques , Genetic Therapy , Genetic Vectors , Humans , Male , Middle Aged
15.
BMJ ; 309(6960): 1020-1, 1994 Oct 15.
Article in English | MEDLINE | ID: mdl-7950709
17.
Hum Mol Genet ; 2(2): 159-63, 1993 Feb.
Article in English | MEDLINE | ID: mdl-7684637

ABSTRACT

Traditionally, DNA used for PCR-based diagnostic analysis has originated from white cells fractionated from whole blood. Although this method yields substantial quantities of DNA, there are some drawbacks to the procedure, including the inconvenience of drawing blood, risk of exposure to blood-borne pathogens, liquid sample handling, and the somewhat involved extraction procedure. Alternatively, DNA for genetic diagnosis has been derived from finger stick blood samples, hair roots, cheek scrapings, and urine samples. Oral saline rinses have also been used extensively as a means of collecting buccal epithelial cells as a DNA source. However, this method still requires liquid sample handling. Herein, we present our results involving the rapid extraction of DNA from buccal cells collected on cytology brushes and swabs for use in PCR reactions, specifically the multiplex amplification of 5 exons within the CFTR gene. The quality of DNA isolated from buccal cells, collected in this manner, has been sufficient to reproducibly support multiplex amplification. Cheek cell samples and the DNA prepared from them as described here are highly stable. The success rate of PCR amplification on DNA prepared from buccal cells is 99%. In a blind study comparing the analysis of 12 mutations responsible for cystic fibrosis in multiplex products amplified with DNA from both blood and buccal cell samples from 464 individuals, there was 100% correlation of results for blood and cheek cell DNA, validating the use of DNA extracted from cheek cells collected on cytology brushes for use in genetic testing.


Subject(s)
DNA Mutational Analysis , Membrane Proteins/genetics , Mouth Mucosa/cytology , Polymerase Chain Reaction , Base Sequence , Cheek , Cystic Fibrosis/diagnosis , Cystic Fibrosis/genetics , Cystic Fibrosis/prevention & control , Cystic Fibrosis Transmembrane Conductance Regulator , DNA/blood , DNA Mutational Analysis/instrumentation , Feasibility Studies , Genetic Testing , Humans , Molecular Sequence Data , Single-Blind Method , Specimen Handling
18.
Med Secoli ; 5(3): 379-403, 1993.
Article in Italian | MEDLINE | ID: mdl-11640159

ABSTRACT

For the present study in the history of Italian medical thought original texts published during the first cholera epidemic in Italy (1835-37) by Tommasini, Giacomini, Pirondi, Bufalini, are analyzed. Tommasini, Giacomini and Pirondi, belonging to the Rasorian School, nonetheless develope different positions: Pirondi is a strict Rasorian, Giacomini defines a neuro-vascular theory including a symptomatic analysis, Tommasini syncretizes the Italian irritation theses, expanding Rasorian thought to include qualitative variations. Bufalini, by contrast, develops an epidemiological-materialistic theory.


Subject(s)
Cholera/history , Disease Outbreaks/history , Philosophy, Medical/history , History, 19th Century , Humans
19.
Ann Neurol ; 31(4): 425-30, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1375014

ABSTRACT

We have reported previously that striatal projection neurons are differentially affected in the course of Huntington's disease, and in a prior patient report we noted that differential loss of striatal projection neurons occurs also in patients with presymptomatic Huntington's disease. Striatal neurons projecting to the external segment of the globus pallidus or the substantia nigra show evident loss, whereas those projecting to the internal segment of the globus pallidus appear relatively spared at presymptomatic and early stages of symptomatic Huntington's disease. We now report similar findings in a second apparently presymptomatic Huntington's disease allele carrier.


Subject(s)
Corpus Striatum/physiopathology , Globus Pallidus/physiopathology , Huntington Disease/physiopathology , Neurons/physiology , Synaptic Transmission , Adult , Cell Survival , Corpus Striatum/metabolism , Corpus Striatum/pathology , Enkephalins/metabolism , Glial Fibrillary Acidic Protein/metabolism , Globus Pallidus/metabolism , Globus Pallidus/pathology , Humans , Huntington Disease/metabolism , Huntington Disease/pathology , Immunohistochemistry , Male , Substance P/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...